Skip to content

Application of Facial Expression Analysis Technology for Differential Diagnosis Between Depression with Psychotic Symptoms and Schizophrenia

Application of Facial Expression Analysis Technology for Differential Diagnosis Between Depression with Psychotic Symptoms and Schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107753
Enrollment
Unknown
Registered
2025-08-18
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression with psychotic symptoms

Interventions

Depression with psychotic symptoms group:no intervetion
Healthy controls group:no intervetion
Schizophrenia group:no intervetion

Sponsors

Beijing An Ding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Schizophrenia Group :(1) Age 15-45 years, regardless of gender; (2) Screened using the MINI 7.0 and meeting the diagnostic criteria for current schizophrenia; (3) Non-refractory schizophrenia (failed to respond to two or more prior antipsychotic medications); (4) Junior high school education or higher, able to understand and cooperate with all examinations and assessments; (5) Informed consent signed by the subject and/or the subject's family member or guardian. 2.Depression with psychotic symptoms group: (1) Age 15-45 years, regardless of gender; (2) Screened using the Mini-International Neuropsychiatric Interview (MINI) 7.0 based on the Diagnostic and Statistical Manual of Mental Disorders (5th edition) (DSM-5), meeting the diagnostic criteria for depression with psychotic symptoms; (3) Score >= 8 on the 17 items of the Hamilton Depression Rating Scale; (4) Junior high school education or above, able to understand and cooperate with all examinations and assessments; (5) Informed consent signed by the subject and/or the subject's family or guardian; 3.Healthy control group: (1) Aged 15-45 years, regardless of gender; (2) Healthy individuals who do not meet the criteria for any Axis I or Axis II disease diagnosis using the MINI 7.0 screening and have no family history of mental illness in two or three generations; (3) Junior high school education or above, who can understand and cooperate with all examinations and assessments; (4) Informed consent signed by the subject and/or the subject's family member or guardian (if the subject is a minor).

Exclusion criteria

Exclusion criteria: 1. Comorbidity with other mental disorders; 2. Severe heart, liver, kidney, or nervous system disease or visual or hearing impairment; 3. History of alcohol or drug abuse in the past 12 months or alcohol or drug dependence in the past 6 months; 4. Significant acute extrapyramidal symptoms (such as acute dystonia); 5. Score of 1 or higher on any two of items 2, 3, 4, and 9 of the Simpson-Angus Extrapyramidal Symptom Rating Scale (SAS); 6. Score of 2 or higher on any one of items 1-4 of the Abnormal Involuntary Movement Scale (AMIS) (assessing facial and oral movements).

Design outcomes

Primary

MeasureTime frame
Facial expression features;

Secondary

MeasureTime frame
Positive and negative syndrome scale;17-item Hamilton Depression Rating Scale(Depressed patients with psychotic symptoms require evaluation)or Calgary depression scale for schizophrenia(Patients with schizophrenia need assessment);Abnormal Involuntary Movement Scale;Simpson-Angus Scale;

Countries

China

Contacts

Public ContactLIfeng

Beijing An Ding Hospital, Capital Medical University

lifengweiyi023@126.com+86 10 58303129

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026